Single‐Atom Catalysts with Isolated Cu1‐N4 Sites for Atopic Dermatitis Cascade Catalytic Therapy via Activating PPAR Signaling
Le Kuai,Fang Huang,Lijie Mao,Yi Ru,Jingsi Jiang,Jiankun Song,Si Chen,Ke Li,Yongyong Li,Haiqing Dong,Xiangyu Lu,Bin Li,Jianlin Shi
DOI: https://doi.org/10.1002/smll.202407365
IF: 13.3
2024-10-06
Small
Abstract:A single‐atom copper catalyst (Cu1‐N4 ISAC), featuring superoxide dismutase‐, glutathione peroxidase‐, and ascorbate peroxidase‐like activities, can effectively catalyze the conversion of O2•– to H2O2, and H2O2 to H2O. Such cascade catalytic properties make Cu1‐N4 ISACs effectively ameliorate atopic dermatitis (AD) symptoms via activating PPAR signaling, which is suppressed in AD patients. Atopic dermatitis (AD) is one of the most common allergic skin disorders affecting over 230 million people worldwide, while safe and efficient therapeutic options for AD are currently rarely available. Reactive oxygen species (ROS) accumulation plays a key role in AD's disease progression. Therefore, a novel single‐atom catalyst is designed with isolated Cu1‐N4 sites anchored on carbon support (Cu1‐N4 ISAC), featuring triple antioxidant enzyme‐mimicking activities, for efficient AD cascade catalytic therapy (CCT). The excellent superoxide dismutase (SOD)‐, glutathione peroxidase (GPx)‐, and ascorbate peroxidase (APx)‐like activities of Cu1‐N4 ISACs enable the sequential conversion of O2•− to H2O2 and then to harmless H2O, thereby protecting keratinocytes from oxidative stress damage. Notably, two novel experimental methods are developed to directly prove the SOD‐GPx and SOD‐APx cascade catalytic activities for the first time. In vivo experiments show that Cu1‐N4 ISACs are more potent than a recommended typical medicine (halcinonide solution). Additionally, RNA sequencing and bioinformatic analysis reveal that Cu1‐N4 ISACs reduce inflammation and inhibit ROS production by activating PPAR signaling, which is aberrantly reduced in AD. Therefore, the synthesized catalytic medicine offers an alternative to alleviate AD and has the potential to serve as PPAR agonists for treating similar diseases.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology